GL1X · GenesisL1 explorer

Research workbench

Lyn tyrosine kinase domain-dasatinib complex

Analyse Lyn tyrosine kinase domain-dasatinib complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZVA
Type
protein
Length
261 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase lyn
EC
2.7.10.2
UniProt
P25911
Ligands
1N1
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase lyn (EC 2.7.10.2)protein26139% helix, 20% strandP25911

Ligands and binding sites

  • 1N1 · N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15260.720.81471N1

Compared structures

  • 2ZVA · Lyn Tyrosine Kinase Domain-Dasatinib complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P25911 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase lyn (P25911) · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.